With a staggering 28.4 million new cancer cases projected by 2024, the urgency for improved treatments has never been greater [1].
While the rapid advancement of personalized treatments has transformed oncology, it has brought with it a host of new considerations, complexities, and challenges that sponsors must overcome.
This free ebook shines a light on how adopting agile, flexible solutions such as adaptive trial designs and customizable assays can support oncology trials